CASTLE BIOSCIENCES, INC. Capital Expenditures
CASTLE BIOSCIENCES, INC. (CSTL) reported Capital Expenditures of $21.11 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-07-30
- CASTLE BIOSCIENCES, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $8.65M, a 6.62% decline year-over-year.
- CASTLE BIOSCIENCES, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $12.46M, a 162.76% increase year-over-year.
- CASTLE BIOSCIENCES, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $7.18M, a 5.06% decline year-over-year.
- CASTLE BIOSCIENCES, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $14.83M, a 132.58% increase year-over-year.
- CASTLE BIOSCIENCES, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $36.02M, a 27.17% increase from fiscal 2024.
- CASTLE BIOSCIENCES, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $28.33M, a 107.96% increase from fiscal 2023.
- CASTLE BIOSCIENCES, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $13.62M, a 141.85% increase from fiscal 2022.
- CASTLE BIOSCIENCES, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $5.63M, a 61.70% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 6 month as first filed | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $21.11M 10-Q · filed 2026-07-30 | $28.29M derived: sum of 3 quarters · filed 2026-07-30 | $43.12M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2026-03-31 | $12.46M 10-Q · filed 2026-05-06 | $19.64M derived: sum of 2 quarters · filed 2026-05-06 | $34.47M derived: sum of 3 quarters · filed 2026-05-06 | $43.74M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-12-31 | $7.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $22.02M derived: sum of 2 quarters · filed 2026-02-26 | $31.28M derived: sum of 3 quarters · filed 2026-07-30 | $36.02M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $14.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $24.10M derived: sum of 2 quarters · filed 2026-07-30 | $28.84M 10-Q · filed 2025-11-03 | $36.40M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-06-30 | $9.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $14.00M 10-Q · filed 2026-07-30 | $21.57M derived: sum of 3 quarters · filed 2026-07-30 | $27.95M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-03-31 | $4.74M 10-Q · filed 2026-05-06 | $12.31M derived: sum of 2 quarters · filed 2026-05-06 | $18.68M derived: sum of 3 quarters · filed 2026-05-06 | $23.91M derived: sum of 4 quarters · filed 2026-05-06 | ||
| 2024-12-31 | $7.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $13.95M derived: sum of 2 quarters · filed 2026-02-26 | $19.17M derived: sum of 3 quarters · filed 2026-02-26 | $28.33M 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $6.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $11.61M derived: sum of 2 quarters · filed 2025-11-03 | $20.76M 10-Q · filed 2025-11-03 | $24.55M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | $5.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $14.38M 10-Q · filed 2025-08-04 | $18.17M derived: sum of 3 quarters · filed 2026-02-26 | $20.63M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-03-31 | $9.15M 10-Q · filed 2025-05-05 | $12.95M derived: sum of 2 quarters · filed 2026-02-26 | $15.40M derived: sum of 3 quarters · filed 2026-02-26 | $19.43M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2023-12-31 | $3.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $6.25M derived: sum of 2 quarters · filed 2026-02-26 | $10.28M derived: sum of 3 quarters · filed 2026-02-26 | $13.62M 10-K · filed 2026-02-26 | ||
| 2023-09-30 | $2.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $6.49M derived: sum of 2 quarters · filed 2024-11-04 | $9.83M 10-Q · filed 2024-11-04 | $11.62M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | $4.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $7.37M 10-Q · filed 2024-08-05 | $9.16M derived: sum of 3 quarters · filed 2025-02-27 | $11.20M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | $3.34M 10-Q · filed 2024-05-02 | $5.13M derived: sum of 2 quarters · filed 2025-02-27 | $7.16M derived: sum of 3 quarters · filed 2025-02-27 | $8.57M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | $1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $3.83M derived: sum of 2 quarters · filed 2025-02-27 | $5.23M derived: sum of 3 quarters · filed 2025-02-27 | $5.63M 10-K · filed 2025-02-27 | ||
| 2022-09-30 | $2.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $3.44M derived: sum of 2 quarters · filed 2023-11-02 | $3.85M 10-Q · filed 2023-11-02 | $4.74M derived: sum of 4 quarters · filed 2023-11-02 | ||
| 2022-06-30 | $1.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $1.81M 10-Q · filed 2023-08-02 | $2.70M derived: sum of 3 quarters · filed 2023-08-02 | $3.63M derived: sum of 4 quarters · filed 2023-08-02 | ||
| 2022-03-31 | $402.00K 10-Q · filed 2023-05-03 | $1.29M derived: sum of 2 quarters · filed 2023-05-03 | $2.22M derived: sum of 3 quarters · filed 2023-05-03 | $3.13M derived: sum of 4 quarters · filed 2023-05-03 | ||
| 2021-12-31 | $893.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $1.82M derived: sum of 2 quarters · filed 2023-02-28 | $2.73M derived: sum of 3 quarters · filed 2023-02-28 | $3.48M 10-K · filed 2023-02-28 | ||
| 2021-09-30 | $927.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $1.84M derived: sum of 2 quarters · filed 2022-11-02 | $2.59M 10-Q · filed 2022-11-02 | $3.18M derived: sum of 4 quarters · filed 2022-11-02 | ||
| 2021-06-30 | $913.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $1.66M 10-Q · filed 2022-08-08 | $2.25M derived: sum of 3 quarters · filed 2022-08-08 | $4.16M derived: sum of 4 quarters · filed 2022-08-08 | ||
| 2021-03-31 | $750.00K 10-Q · filed 2022-05-09 | $1.34M derived: sum of 2 quarters · filed 2022-05-09 | $3.25M derived: sum of 3 quarters · filed 2022-05-09 | $5.00M derived: sum of 4 quarters · filed 2022-05-09 | ||
| 2020-12-31 | $589.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $2.50M derived: sum of 2 quarters · filed 2022-02-28 | $4.25M derived: sum of 3 quarters · filed 2022-02-28 | $4.75M 10-K · filed 2022-02-28 | ||
| 2020-09-30 | $1.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $3.66M derived: sum of 2 quarters · filed 2021-11-08 | $4.16M 10-Q · filed 2021-11-08 | $4.51M derived: sum of 4 quarters · filed 2021-11-08 | ||
| 2020-06-30 | $1.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $2.26M 10-Q · filed 2021-08-09 | $2.60M derived: sum of 3 quarters · filed 2021-08-09 | $2.77M derived: sum of 4 quarters · filed 2021-08-09 | ||
| 2020-03-31 | $500.00K 10-Q · filed 2021-05-10 | $847.00K derived: sum of 2 quarters · filed 2021-05-10 | $1.01M derived: sum of 3 quarters · filed 2021-05-10 | $1.19M derived: sum of 4 quarters · filed 2021-05-10 | ||
| 2019-12-31 | $347.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $513.00K derived: sum of 2 quarters · filed 2021-03-11 | $693.00K derived: sum of 3 quarters · filed 2021-03-11 | $937.00K 10-K · filed 2021-03-11 | ||
| 2019-09-30 | $166.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $346.00K derived: sum of 2 quarters · filed 2020-11-09 | $590.00K 10-Q · filed 2020-11-09 | $589.66K 10-Q · filed 2019-11-12 | $595.38K derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | $180.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $424.00K 10-Q · filed 2020-08-10 | $424.47K 10-Q · filed 2019-09-03 | $429.38K derived: sum of 3 quarters · filed 2020-08-10 | $516.39K derived: sum of 4 quarters · filed 2020-08-10 | |
| 2019-03-31 | $244.00K 10-Q · filed 2020-05-11 | $249.38K derived: sum of 2 quarters · filed 2020-05-11 | $336.39K derived: sum of 3 quarters · filed 2020-05-11 | |||
| 2018-12-31 | $5.38K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $92.39K derived: sum of 2 quarters · filed 2020-03-10 | $277.00K 10-K · filed 2020-03-10 | |||
| 2018-09-30 | $87.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $271.62K 10-Q · filed 2019-11-12 | ||||
| 2018-06-30 | $184.61K 10-Q · filed 2019-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |